
The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, the rest of North America, the United Kingdom, the rest of Europe, and internationally. The company is headquartered in Englewood, Colorado.
| Revenue (TTM) | $1.84B |
| Gross Profit (TTM) | $505.90M |
| EBITDA | $190.90M |
| Operating Margin | 8.08% |
| Return on Equity | 9.13% |
| Return on Assets | 5.11% |
| Revenue/Share (TTM) | $74.40 |
| Book Value | $54.54 |
| Price-to-Book | 1.72 |
| Price-to-Sales (TTM) | 1.25 |
| EV/Revenue | 1.145 |
| EV/EBITDA | 11.02 |
| Quarterly Earnings Growth (YoY) | 33.00% |
| Quarterly Revenue Growth (YoY) | 11.80% |
| Shares Outstanding | $24.63M |
| Float | $24.32M |
| % Insiders | 1.35% |
| % Institutions | 102.01% |
Volatility is currently expanding

The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.

With the oilfield segment leading topline growth, even more growth should be expected as the adoption of DRA expands and the firm re-enters the Mexico market. In Q2 of 2026, revenue grew 12%, beating estimates by $34.17 million. The firm is now in a better financial position to command a higher sales multiple. The Performance chemical segment still experiences volume declines, raising concerns about the firm over investing by adding 10% capacity in a weak market.

Innospec's Q2 earnings beat estimates as all three businesses delivered revenue growth, while a debt-free balance sheet supports further investment.

Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.

Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript

Innospec NASDAQ: IOSP reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities.

Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent

Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Investors with an interest in Chemical - Diversified stocks have likely encountered both Innospec (IOSP) and Air Products and Chemicals (APD). But which of these two stocks is more attractive to value investors?

Investors looking for stocks in the Chemical - Diversified sector might want to consider either Innospec (IOSP) or Air Liquide (AIQUY). But which of these two stocks presents investors with the better value opportunity right now?
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on IOSP and any ticker you trade — then tracks every position and per-strategy win rate.